Establishing the clinical and economic benefits of adherence to 5-alpha reductase inhibitors in benign prostatic hyperplasia: an assessment of Medicare and Medicaid patients. [electronic resource]
Producer: 20130429Description: 2593-600 p. digitalISSN:- 1744-7666
- 5-alpha Reductase Inhibitors -- administration & dosage
- Aged
- Aged, 80 and over
- Cohort Studies
- Cost Savings
- Databases, Factual
- Follow-Up Studies
- Health Care Costs
- Humans
- Male
- Medicaid
- Medicare
- Medication Adherence
- Middle Aged
- Proportional Hazards Models
- Prostate -- drug effects
- Prostatic Hyperplasia -- drug therapy
- Retrospective Studies
- United States
- Urinary Retention -- economics
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.